Interaction between cisplatin and gemcitabine in vitro and in vivo.
about
Synthetic lethality in lung cancer and translation to clinical therapiesGemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsA phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumA phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.A 21-day schedule of gemcitabine and cisplatin administration in the treatment of advanced non-small cell lung carcinoma: a phase II studyGemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan[Phase II trial of improved regimen with gemcitabine in patients with advanced non-small cell lung cancer].Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignanciesTriplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancerGemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysisCombination studies with gemcitabine in the treatment of non-small-cell lung cancer.The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancerGemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer.Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer.Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?A successful treatment by hepatic arterial infusion therapy for advanced, unresectable biliary tract cancer.Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer.A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
P2860
Q28072904-2F3D674C-B7E5-400E-8F1E-61A8AA744A3EQ30318857-4F7EF86E-0BED-4ACF-BEBC-47B089897BCEQ33287243-252C6EB4-925D-4A7B-9297-0A4FA6D996D3Q33360400-E7D52B80-8B43-476B-8500-212FD5DA8195Q33365711-15632EB3-BA55-4FFE-9BAC-8D90D5BA8FDBQ33383608-5A5DA7ED-CD24-488E-ACF3-4A9B8F40A605Q33389166-C24B0429-88CF-48BA-AE8E-95172BA560FEQ33390747-EB54579B-3D9F-432C-BC46-E3261964244AQ33399148-E42ECF8F-2374-465D-83E4-C6083D2CCDD9Q33423203-D31B4A20-483D-45CD-AC0C-DEC7A0CCA058Q33428016-F04789E7-9B39-4BC7-B331-3948DCCBEC6CQ33430378-5E86DCB5-C6BE-4B8E-AB95-C13930EEF460Q33503456-47F44160-F9FB-47F9-8242-F462A76B8256Q33597112-21E1DAD4-695A-4051-B4FC-DE664CA2B7A8Q34528724-0B60F696-30CB-4FC0-B4FE-3BECC4D04342Q34746035-2797FE94-1F97-4C9D-BD85-611250F48124Q34811103-B75C4CA8-7A17-485C-BDEE-FCC7B5E5ADA9Q35612005-D89E7E11-3A21-4390-BD68-0B5DB9B422DDQ36452263-BBDB0DBB-C5A6-4B92-A8AC-E6848A88BA9EQ36494203-56338D3C-D92B-4FE3-AE89-8865CB910FD6Q36614893-9C193832-5D58-420C-AECE-78A99B01F28EQ36643866-C42744A5-3D54-4C33-8DA7-9887D8A9DC0EQ36646087-61AF69E0-8321-4F1E-A0F9-F66173FDDBA0Q37530604-FC9BA897-9576-437C-8A59-30B5D412C98DQ37729218-38C745AF-2FF3-483F-BF0E-D44E09416735Q38611177-860B0106-5FB2-4040-8EE7-7937EBFA1415Q39022032-636D54B4-999E-4231-8CAF-A9AE98540C1BQ41128514-6D161510-DD7D-4B10-9F37-8AED96A5373DQ41905474-FDEF84F5-E291-4C9A-9972-58D9D1932518Q42690847-6A720006-372B-4ED8-91F2-12577EDAB62C
P2860
Interaction between cisplatin and gemcitabine in vitro and in vivo.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Interaction between cisplatin and gemcitabine in vitro and in vivo.
@en
type
label
Interaction between cisplatin and gemcitabine in vitro and in vivo.
@en
prefLabel
Interaction between cisplatin and gemcitabine in vitro and in vivo.
@en
P2093
P1433
P1476
Interaction between cisplatin and gemcitabine in vitro and in vivo
@en
P2093
A M Bergman
B J Braakhuis
C M Kuiper
G J Peters
V W Ruiz van Haperen
P433
4 Suppl 11
P577
1995-08-01T00:00:00Z